[seopress_breadcrumbs]

Episode #89 – “Evolving Ourselves” – an Interview with Author, Speaker, and Investor Juan Enriquez

•

April 5, 2015

Episode #89 - “Evolving Ourselves” - an Interview with Author, Speaker, and Investor Juan Enriquez

Juan Enriquez gave a TED talk in 2009 called “The next species of human,” and video went viral – and is now one of the most popular futurist talks in TED history. In addition to previously founding the Life Sciences Project at the Harvard Business School, Juan is now managing partner in Excell Venture Management in Boston, MA.

In this interview we discuss Juan’s thoughts about the most relevant technologies that might “tinker with what’s human,” and which such technologies might be the first to require serious ethical consideration from humanity as a whole, in the public and private sectors.

Check out this episode on Libsyn.

Listen on iTunes.

image credit: tedconfblog.files.wordpress.com

Recommended from Emerj

Governing AI while Delivering Business Impact – with Leaders from NLP Logix and TD Bank

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Government and industry leaders increasingly agree that governance is now foundational to AI — not optional — because…

Riya Pahuja

•

January 16, 2026

Governing Agentic AI at Enterprise Scale From Insight to Action – with Leaders from AnswerRocket and Bayer

This interview analysis is sponsored by AnswerRocket and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Enterprise organizations face decision-making pressures that are strikingly consistent across industries. As product portfolios expand, markets fragment, and…

Matthew DeMello

•

January 14, 2026

Enhancing Clinical Workflows and Optimizing Efficiencies – with Patricio La Rosa of Bayer

Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high as $2 billion per drug and are accompanied by protracted timelines of 10-15 years. Pharmaceutical companies are turning to AI to shorten discovery timelines while dramatically upholding rigorous standards. AI-driven approaches have demonstrated meaningful…

Sharon Moran

•

January 12, 2026

Scaling Global Trade with AI-Powered Tools for SMBs – with Kuo Zhang of Alibaba.com

SMBs are overwhelmed by multi-step operational work that drains time and headcount. Global trade processes remain slow, fragmented, and opaque. For all the focus on large enterprises in AI adoption, World Trade Organization working group documentation notes that SMBs make up nearly 90–95% of all global businesses and account for 60% of worldwide employment. Other…

Riya Pahuja

•

January 12, 2026

From Manual Reports to Generative and Agentic AI Automation in Finance – with Pavlé Sabic of Moody’s

This interview analysis is sponsored by Moody’s and was written, edited, and published in alignment with ourEmerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. High-stakes enterprise decisions are growing too complex for traditional automation to handle as fragmented data and regulatory pressures overwhelm…

Riya Pahuja

•

January 8, 2026

Artificial Intelligence at Edward Jones – Two Use Cases

Edward Jones is a U.S.-based financial services firm focused on individual investors and small businesses. The company reported $16 billion in revenue for 2024, with fees contributing nearly $13.2 billion, and net income reached to $1.98 billion. The firm ranked No. 260 on the Fortune 500, based on its $16.3 billion in revenue. It has…

Riya Pahuja

•

January 5, 2026

How AI is Orchestrating the Insurance Supply Chain – with Marc Fredman of CCC Intelligent Solutions

Modern vehicles are increasingly equipped with advanced technologies, including AI-powered sensors, image-based diagnostics, and automated damage detection, which enable faster and more accurate claims assessments. Recent research from Helwan University, Cairo, presents an academic Cost Estimation System that combines computer vision models with structured customer data to assess vehicle damage severity and estimate repair costs,…

Riya Pahuja

•

December 29, 2025

Making Microsoft Copilot and ChatGPT Enterprise Work for You – with Matt Berseth and Russell Dixon of NLP Logix

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. The current increase in capital allocation to GenAI — enterprise AI assistants and collaboration platforms like ChatGPT Enterprise…

Matthew DeMello

•

December 23, 2025

Scaling Auditable Agentic Workflows in Financial Services – with Leaders from Moody’s and Prudential Insurance

This article is sponsored by Moody’s and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Regulated industries face compounding operational and regulatory pressures that steadily erode speed, accuracy, and competitiveness. Analysts lose hours to manual…

Marilie Fouche

•

December 22, 2025

Artificial Intelligence at Samsung – Two Use Cases

Samsung is a leading technology enterprise committed to helping people live more connected lives through innovative consumer electronics. The company has grown into a global powerhouse with a diverse range of businesses, including electronics, finance, chemicals, and more. In 2024, Samsung reported an annual revenue of $205 billion. Samsung also employed 262,647 people globally as…

Ashwin Telang

•

December 22, 2025

Enhancing Drug Safety with AI and Automation Technologies – with Marie Flanagan of IQVIA

Generative AI has been accelerating transformation across the life sciences, leaving pharmaceutical companies and clinical research organizations facing a dual challenge: modernizing pharmacovigilance while maintaining uncompromising standards for patient safety, data integrity, and global regulatory compliance. This delicate balance is most critical in adverse event detection and signaling, where a single missed risk can trigger…

Sharon Moran

•

December 15, 2025

Connecting the Dots Across Discovery – with Ben Ninio of Deloitte

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. In R&D-intensive sectors such as life sciences, agriculture, and advanced materials, a familiar challenge persists: fragmented data ecosystems,…

Matthew DeMello

•

December 11, 2025

Search site

Search site

Episode #89 – “Evolving Ourselves” – an Interview with Author, Speaker, and Investor Juan Enriquez

Recommended from Emerj

Governing AI while Delivering Business Impact – with Leaders from NLP Logix and TD Bank

Governing Agentic AI at Enterprise Scale From Insight to Action – with Leaders from AnswerRocket and Bayer

Enhancing Clinical Workflows and Optimizing Efficiencies – with Patricio La Rosa of Bayer

Scaling Global Trade with AI-Powered Tools for SMBs – with Kuo Zhang of Alibaba.com

From Manual Reports to Generative and Agentic AI Automation in Finance – with Pavlé Sabic of Moody’s

Artificial Intelligence at Edward Jones – Two Use Cases

How AI is Orchestrating the Insurance Supply Chain – with Marc Fredman of CCC Intelligent Solutions

Making Microsoft Copilot and ChatGPT Enterprise Work for You – with Matt Berseth and Russell Dixon of NLP Logix

Scaling Auditable Agentic Workflows in Financial Services – with Leaders from Moody’s and Prudential Insurance

Artificial Intelligence at Samsung – Two Use Cases

Enhancing Drug Safety with AI and Automation Technologies – with Marie Flanagan of IQVIA

Connecting the Dots Across Discovery – with Ben Ninio of Deloitte

Customize Your Experience

Episode #89 – “Evolving Ourselves” – an Interview with Author, Speaker, and Investor Juan Enriquez

Share article

Subscribe to updates

Recommended from Emerj

Governing AI while Delivering Business Impact – with Leaders from NLP Logix and TD Bank

Governing Agentic AI at Enterprise Scale From Insight to Action – with Leaders from AnswerRocket and Bayer

Enhancing Clinical Workflows and Optimizing Efficiencies – with Patricio La Rosa of Bayer

Scaling Global Trade with AI-Powered Tools for SMBs – with Kuo Zhang of Alibaba.com

From Manual Reports to Generative and Agentic AI Automation in Finance – with Pavlé Sabic of Moody’s

Artificial Intelligence at Edward Jones – Two Use Cases

How AI is Orchestrating the Insurance Supply Chain – with Marc Fredman of CCC Intelligent Solutions

Making Microsoft Copilot and ChatGPT Enterprise Work for You – with Matt Berseth and Russell Dixon of NLP Logix

Scaling Auditable Agentic Workflows in Financial Services – with Leaders from Moody’s and Prudential Insurance

Artificial Intelligence at Samsung – Two Use Cases

Enhancing Drug Safety with AI and Automation Technologies – with Marie Flanagan of IQVIA

Connecting the Dots Across Discovery – with Ben Ninio of Deloitte

This Content is Exclusive to Emerj Plus Members

In-Depth Analysis

Exclusive AI Capabilities Matrix

Exclusive AI White Paper Library

Best Practices and executive guides

Register

Customize Your Experience